coronary atherosclerosis	is a form of	atherosclerotic cardiovascular disease
coronary atherosclerosis	is risk factor for	myocardial infarction
coronary atherosclerosis	is risk factor for	unstable angina
coronary atherosclerosis	leads to	luminal stenosis
luminal stenosis	causes	myocardial ischemia
multivessel disease	results in	higher risk of myocardial infarction
coronary atherosclerosis	progresses to	chronic coronary syndrome
myocardial infarction	may cause	heart failure
myocardial infarction	may cause	cardiogenic shock
myocardial infarction	managed with	PCI
myocardial infarction	managed with	thrombolysis
myocardial infarction	increases	mortality
stable angina	is treated with	antianginal therapy
unstable angina	treated with	antiplatelet therapy
acute coronary syndrome	includes	unstable angina
acute coronary syndrome	managed with	anti-ischemic therapy
left ventricular dysfunction	leads to	heart failure
systolic dysfunction	leads to	heart failure
atrial fibrillation	increases risk of	thromboembolism
atrial fibrillation	increases risk of	stroke
atrial fibrillation	treated with	anticoagulation therapy
PCI	is a form of	revascularization
CABG	is a form of	revascularization
revascularization	improves	myocardial perfusion
drug-eluting stent	reduces	restenosis
bare-metal stent	increases	restenosis
PCI	restores	coronary flow
CABG	improves	survival
beta blocker therapy	reduces	myocardial oxygen demand
ACE inhibitor therapy	reduces	afterload
ARB therapy	reduces	afterload
statin therapy	reduces	LDL cholesterol
lipid-lowering therapy	reduces	cardiovascular events
antiplatelet therapy	reduces	thrombotic events
dual antiplatelet therapy	reduces	stent thrombosis
thrombolysis	dissolves	clots
anticoagulation therapy	reduces	thromboembolism
angiotensin receptor blockers	prevent	remodeling
ACE inhibitors	protect	myocardium
statins	stabilize	atherosclerotic plaques
lifestyle modification	improves	cardiovascular risk profile
smoking cessation	improves	prognosis in CAD
physical activity	reduces	cardiovascular risk
dietary modification	reduces	LDL
blood pressure control	reduces	cardiovascular events
hypertension	increases risk for	coronary atherosclerosis
diabetes mellitus	increases risk for	coronary atherosclerosis
diabetes mellitus	worsens	prognosis in CAD
hyperlipidemia	contributes to	atherosclerosis
obesity	increases risk for	CAD
smoking	increases risk for	CAD
family history	increases risk for	premature CAD
age	increases risk for	CAD
chronic kidney disease	worsens	CAD prognosis
anemia	worsens	CAD prognosis
inflammation	promotes	atherosclerosis
C-reactive protein	is a marker for	inflammation
lipoprotein(a)	increases	atherosclerotic risk
homocysteine	associated with	vascular risk
coronary angiography	visualizes	coronary arteries
coronary CT angiography	visualizes	coronary arteries
stress testing	detects	inducible ischemia
cardiac MRI	assesses	myocardial viability
echocardiography	assesses	left ventricular function
electrocardiography	detects	ischemia
troponin	rises in	myocardial infarction
CK-MB	is a biomarker for	myocardial injury
BNP	indicates	heart failure
lipid panel	guides	lipid-lowering therapy
left main disease	implies	high-risk CAD
multivessel disease	indicates	worse prognosis
stent thrombosis	leads to	myocardial infarction
heart failure	predicts	higher mortality
ventricular arrhythmia	causes	sudden death
antiplatelet therapy	prevents	platelet aggregation
ACE inhibitors	reduce	mortality after MI
ARBs	reduce	afterload
MR antagonists	reduce	mortality in heart failure
SGLT2 inhibitors	reduce	cardiovascular events
furosemide	reduces	fluid overload
spironolactone	reduces	mortality in heart failure
digoxin	controls	heart rate in atrial fibrillation
warfarin	reduces	embolic risk in AF
DOACs	reduce	stroke in nonvalvular AF
anticoagulation therapy	increases	bleeding risk
statin therapy	prevents	plaque progression
new cardiology referral	improves	quality of life
implantable cardioverter-defibrillator	reduces	sudden cardiac death
cardiac resynchronization therapy	improves	cardiac function
readmission	related to	heart failure
mortality	associated with	CAD severity
recurrent chest pain	correlates with	CAD progression
stroke	risk elevated by	atrial fibrillation
LDL cholesterol	is a target of	lipid-lowering therapy
hs-CRP	indicates	inflammation
troponin	elevates in	myocardial infarction
BNP	increases with	heart failure
cardiac rehabilitation	improves	quality of life
weight reduction therapy	reduces	cardiovascular risk
polypharmacy	increases	adverse drug events
